COSMO PHARMACEUTICALS NV (C43.DE) Stock Cash Flow
FRA:C43 - Deutsche Boerse Ag - NL0011832936 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 153.37M | 7.61M | 24.47M | 24.00M | -6.93M | |||
| Depreciation Amortization | 12.29M | 11.85M | 13.86M | 7.37M | 6.04M | |||
| Change In Working Capital | -4.38M | 6.30M | -15.27M | -7.70M | -2.27M | |||
| Interest Paid | 0.00 | 4.38M | 4.38M | 4.38M | 4.38M | |||
| Taxes Paid | 7.47M | 3.98M | 1.96M | 2.63M | -2.87M | |||
| Other non cash items | 1.14M | 11.53M | 10.17M | -11.06M | 16.15M | |||
| OPERATING CASH FLOW | 162.41M | 22.71M | 33.23M | 12.61M | 12.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.65M | -4.40M | -7.31M | -8.50M | -8.09M | |||
| Other Investing Activity | -123.23M | 57.61M | 9.00M | 33.36M | 83.53M | |||
| INVESTING CASH FLOW | -128.88M | 53.22M | 1.69M | 24.86M | 75.45M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.08M | -176.03M | -916.00K | -2.62M | -1.79M | |||
| Stock Issued/Repurchased | -2.55M | -11.79M | -25.23M | -19.75M | -5.72M | |||
| Dividend Paid | -32.09M | -17.07M | -15.61M | N/A | N/A | |||
| Other Financing Activity | -4.50M | -6.38M | -4.38M | -4.88M | -4.38M | |||
| FINANCING CASH FLOW | -40.22M | -211.27M | -46.13M | -27.25M | -11.88M | |||
| Exchange Rate Effect | 715.00K | -210.00K | -1.52M | 2.40M | -997.00K | |||
| CHANGE IN CASH | -5.98M | -135.55M | -12.73M | 12.62M | 75.55M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 162.41M | 22.71M | 33.23M | 12.61M | 12.98M | |||
| Capital Expenditure | -5.65M | -4.40M | -7.31M | -8.50M | -8.09M | |||
| FREE CASH FLOW | 156.76M | 18.31M | 25.92M | 4.11M | 4.90M | |||
All data in EUR